| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Non-Customized |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name | PTD-DBM |
| CAS No. | N/A |
| MF | C124H22N61O28S2 |
| MW | 3082.65 |
PTD-DBM which is short for Protein transduction domain (PTD)-Dvl-binding motif (DBM).
In simple terms, it is a follicle regeneration treatment. More specifically, it is a peptide-based topical scalp treatment which inhibits the follicle shrinking action of the body's hormones and enzymes effectively rescuing the follicle at a stem cell level. Treatment with PTD-DBM both prevents hair loss and promotes the growth of new hair follicles.
Many researchers believe that WNT signaling pathways inside of a cell are responsible for hair follicle development and hair regeneration in humans. These pathways are usually made of proteins and they communicate important cell activity and growth signals to various cells throughout our body.
In an attempt to disrupt the undesirable activity of CXXC5 on hair growth, Korean scientists led by Choi Kang-yeol of Yonsei University discovered a new biochemical substance that can act as an CXXC5 inhibitor and promote hair growth and hair regeneration. The new compound is called PTD-DBM which is short for Protein transduction domain (PTD)-Dvl-binding motif (DBM).
According to clinical studies conducted by Choi and his team, the positive effect of PTD-DBM on hair regeneration is shown in human hair follicle dermal papilla cells which is a very encouraging sign as it is done in human follicles and not another mice model. The research is also published in Journal of Investigative Dermatology and publicized in Korea Times, SCMP, and US National Library of Medicine NIH. It is further reported that maximum results from PTD-DBM hair regeneration is to combine with wound-induced hair follicle development with valproic acid.
5. The Benefits of PTD-DBM Treatment
|
Product name
|
CAS No.
|
|
β-Nicotinamide Mononucleotide (NMN)
|
1094-61-7
|
|
beta-Diphosphopyridine nucleotide (NAD)
|
53-84-9
|
|
Nicotinamide riboside chloride (NRC)
|
23111-00-4
|
|
Nicotinamide Ribose (NR)
|
1341-23-7
|
|
|
53-43
|
Extraction process:
){kind=link}